FindTrial
Sign In

Single arm non-randomized study for Androgenetic Alopecia.

Split scalp study to evaluate the therapeutic efficacy of mesojet cocktail in androgenetic alopecia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/047935
Enrollment
12
Registered
2022-12-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Mesojet cocktail: Dose: 2-3 ml of jet-op lotion Frequency: Weekly once for 10 consecutive weeks Route of administration: Hydroporation Control Intervention1: NA: NA

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients clinically diagnosed with of AGA 2.Age: 18-60 years, 3.Either sex 4.Not on topical minoxidil or other pharmacological treatments that could affect the result

Exclusion criteria

Exclusion criteria: 1.Patient with hypertension, migraine, head injury, mental disorder, scalp infection, epilepsy, stroke 2.Oral treatment to the hair loss within six months 3.Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
To determine the safety and the efficacy of the Mesojet system in treatment of androgenetic alopeciaTimepoint: After 4 months—

Secondary

MeasureTime frame
Hair density will be assessed and analysed with the help of trichoscan as well as global photographs by comparison between baseline and 16 weeksTimepoint: after 4 months—

Countries

India

Contacts

Public ContactDr Megha C

CUTIS Academy of Cutaneous Sciences

drmeghac@cutis.org.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026